These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 26087275)

  • 1. Emerging therapies for the treatment of sepsis.
    Vincent JL
    Curr Opin Anaesthesiol; 2015 Aug; 28(4):411-6. PubMed ID: 26087275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal therapies in sepsis.
    Panagiotou A; Gaiao S; Cruz DN
    J Intensive Care Med; 2013; 28(5):281-95. PubMed ID: 22027760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of sepsis.
    van der Poll T
    Lancet Infect Dis; 2001 Oct; 1(3):165-74. PubMed ID: 11871493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of alkaline phosphatase as a treatment for sepsis-associated acute kidney injury.
    Peters E; Masereeuw R; Pickkers P
    Nephron Clin Pract; 2014; 127(1-4):144-8. PubMed ID: 25343839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel potential therapies for septic shock.
    Azevedo LC; Park M; Schettino GP
    Shock; 2008 Oct; 30 Suppl 1():60-6. PubMed ID: 18704007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible interventional therapies in severe sepsis or septic shock.
    Wu CC
    Acta Anaesthesiol Taiwan; 2012 Jun; 50(2):74-7. PubMed ID: 22769862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging drugs for the treatment of sepsis.
    Heming N; Lamothe L; Ambrosi X; Annane D
    Expert Opin Emerg Drugs; 2016; 21(1):27-37. PubMed ID: 26751198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sepsis immunopathology: perspectives of monitoring and modulation of the immune disturbances.
    Skirecki T; Borkowska-Zielińska U; Złotorowicz M; Hoser G
    Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):123-35. PubMed ID: 22301668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of four immunomodulatory therapies for relapsing-remitting multiple sclerosis: a Markov model based on long-term clinical data.
    Bell C; Graham J; Earnshaw S; Oleen-Burkey M; Castelli-Haley J; Johnson K
    J Manag Care Pharm; 2007 Apr; 13(3):245-61. PubMed ID: 17407391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkaline phosphatase as a treatment of sepsis-associated acute kidney injury.
    Peters E; van Elsas A; Heemskerk S; Jonk L; van der Hoeven J; Arend J; Masereeuw R; Pickkers P
    J Pharmacol Exp Ther; 2013 Jan; 344(1):2-7. PubMed ID: 23131595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rationale for the use of extracorporeal treatments for sepsis].
    Ronco C; D'Intini V; Bellomo R; Ricci Z; Bonello M; Ratanarat R; Salvatori G; Bordoni V; Andricos E; Brendolan A
    Anesteziol Reanimatol; 2005; (2):87-91. PubMed ID: 15938108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Septic shock: new pharmacotherapy options or better trial design?
    Vincent JL; Van Nuffelen M
    Expert Opin Pharmacother; 2013 Apr; 14(5):561-70. PubMed ID: 23452102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem Cell-based Therapies for Sepsis.
    Keane C; Jerkic M; Laffey JG
    Anesthesiology; 2017 Dec; 127(6):1017-1034. PubMed ID: 28872482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy in sepsis - brake or accelerate?
    Steinhagen F; Schmidt SV; Schewe JC; Peukert K; Klinman DM; Bode C
    Pharmacol Ther; 2020 Apr; 208():107476. PubMed ID: 31931100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When and how should sepsis patients be fed?
    Elke G; Kott M; Weiler N
    Curr Opin Clin Nutr Metab Care; 2015 Mar; 18(2):169-78. PubMed ID: 25635596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of high mobility group box-1 protein in severe sepsis.
    Sunden-Cullberg J; Norrby-Teglund A; Treutiger CJ
    Curr Opin Infect Dis; 2006 Jun; 19(3):231-6. PubMed ID: 16645483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and management of abdominal sepsis.
    Sartelli M
    Curr Opin Crit Care; 2020 Apr; 26(2):205-211. PubMed ID: 32004193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombomodulin in sepsis.
    Levi M; Van Der Poll T
    Minerva Anestesiol; 2013 Mar; 79(3):294-8. PubMed ID: 23241735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal immunomodulation.
    Patole S; Vijayakumar P; Jog S
    J Matern Fetal Neonatal Med; 2002 May; 11(5):290-301. PubMed ID: 12389669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediator-specific therapies for the systemic inflammatory response syndrome, sepsis, severe sepsis, and septic shock: present and future approaches.
    Hazinski MF
    Crit Care Nurs Clin North Am; 1994 Jun; 6(2):309-19. PubMed ID: 7946190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.